Home EU to approve Pfizer’s COVID-19 vaccine on December 23 – Reuters

EU to approve Pfizer’s COVID-19 vaccine on December 23 – Reuters

Updated: 15 Dec. 2020 | 11:37

The European Medicines Agency is expected to approve the coronavirus vaccine developed by Pfizer and BioNTech on December 23rd, Reuters reported on Tuesday, citing a German government source.

Market reaction

The market mood remains upbeat following this headline. As of writing, Germany’s DAX 30 Index was up 0.65% on a daily basis at13,310 and the Euro Stoxx 50 Index was gaining 0.46% at 3,520.

Meanwhile, the shared currency clings to modest daily gains against the greenback during the European trading hours. At the moment, the EUR/USD pair is up 0.13% at 1.2160.

FX Street

FXStreet is the leading independent portal dedicated to the Foreign Exchange (Forex) market. It was launched in 2000 and the portal has always been proud of their unyielding commitment to provide objective and unbiased information, to enable their users to take better and more confident decisions.

View all posts by FX Street

WARNING: The content on this site should not be considered investment advice and we are not authorised to provide investment advice. Nothing on this website is an endorsement or recommendation of a particular trading strategy or investment decision. The information on this website is general in nature, so you must consider the information in light of your objectives, financial situation and needs. Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence or obtain advice where necessary. Crypto promotions on this site do not comply with the UK Financial Promotions Regime and is not intended for UK consumers. This website is free for you to use but we may receive a commission from the companies we feature on this site.